Norflex and Obs - a phase IV clinical study of FDA data
Obs is reported only by a few people who take Norflex.
The phase IV clinical study analyzes which people take Norflex and have Obs. It is created by eHealthMe based on reports of 1,642 people who have side effects while taking Norflex from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,642 people reported to have side effects when taking Norflex.
Among them, 2 people (0.12%) have Obs.
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,832 Norflex users for its effectiveness, alternative drugs and more.
What is Obs?
Obs is found to be associated with 199 drugs and 169 conditions by eHealthMe.
Number of Norflex and Obs reports submitted per year:
Gender of people who have Obs when taking Norflex *:
- female: 0.0 %
- male: 100 %
Age of people who have Obs when taking Norflex *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs people take besides Norflex *:
- Zocor: 2 people, 100.00%
- Prevacid 24 Hr: 2 people, 100.00%
- Cozaar: 2 people, 100.00%
- Nexium: 2 people, 100.00%
- Nitrostat: 2 people, 100.00%
- Prevacid: 2 people, 100.00%
- Nexium 24hr: 2 people, 100.00%
- Prilosec: 2 people, 100.00%
- Protonix: 2 people, 100.00%
- Amlodipine: 2 people, 100.00%
Common side effects people have besides Obs *:
- Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 100.00%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 100.00%
- Chronic Kidney Disease: 2 people, 100.00%
- Renal Tubular Necrosis (death of kidney tubules): 1 person, 50.00%
- Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 50.00%
- Acute Kidney Failure: 1 person, 50.00%
Common conditions people have *:
- Thyroid Diseases: 2 people, 100.00%
- Stable Angina (a constant chest pain): 2 people, 100.00%
- Muscle Aches (muscle pain): 2 people, 100.00%
- High Blood Pressure: 2 people, 100.00%
- High Blood Cholesterol: 2 people, 100.00%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 100.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 100.00%
- Cardiac Failure: 2 people, 100.00%
- Panic Reaction: 1 person, 50.00%
- Panic Disorder: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Norflex and have Obs?Check whether Obs is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Obs and when was it recovered:
Expand to all the drugs that have ingredients of orphenadrine citrate:
Alternative drugs to, pros and cons of Norflex:
- Norflex (1,832 reports)
Common Norflex side effects:
Browse all side effects of Norflex:a b c d e f g h i j k l m n o p q r s t u v w x y z
Obs treatments and more:
- Obs (255 reports)
COVID vaccines that are related to Obs:
- Obs in Moderna COVID Vaccine
- Obs in Pfizer BioNTech Covid Vaccine
- Obs in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Obs:
- Obs (199 drugs)
All the conditions that are associated with Obs:
- Obs (169 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xhance and Thrombocytopenia - 3 seconds ago
- Astramorph Pf and Bone Pain Aggravated - 6 seconds ago
- Vincristine Sulfate and Coronary Artery Stenosis - 11 seconds ago
- Alphagan and Hypothermia - 11 seconds ago
- Boniva and Coronary Artery Restenosis - 13 seconds ago
- Cafergot and Ibu drug interaction - 21 seconds ago
- Busulfex and Anxiety Aggravated - 23 seconds ago
- Sandostatin Lar and Septic Rash - 27 seconds ago
- Imuran and Middle Ear Effusion - 27 seconds ago
- Venlafaxine Hydrochloride and Bioflavonoids drug interaction - 27 seconds ago